ACNE THERAPEUTICS MARKET ANALYSIS

The global acne therapeutics market was valued at US$ 6,342.5 Mn in 2022 and is forecast to reach a value of US$ 8,834.9 Mn by 2030 at a CAGR of 4.2% between 2023 and 2030. The global acne therapeutics market is experiencing strong growth due to the growing prevalence of acne and high demand for safe and effective acne therapeutics. Moreover, increasing research and development and growing awareness among people about available treatment options is expected to propel the growth of the market. However, factors such as high demand for generic drugs and safety issues regarding acne products are expected to hamper the market growth.

Global Acne Therapeutics Market: Regional Insights

Based on geography, the global acne therapeutics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period due to the growing burden of acne, increasing awareness among the population, increasing demand for safe and effective acne therapeutics, and introduction of novel products in the region. For instance, according to the American Academy of Dermatology (AAD), acne is a most common skin condition in the United States, affecting up to 50 million people annually. Acne usually begins in puberty and affects many adolescents and young adults. More than 85 percent of people between the ages of 12 and 24 experience at least minor acne.  

Europe and Asia Pacific are also expected to witness robust growth in the global acne therapeutics market owing to the growing burden of acne, increasing demand for acne therapeutics, increasing awareness among people and introduction of novel drugs in these regions. For instance, prevalence of acne is higher in countries with a higher socio-demographic index, particularly Western Europe, East Asia, and high-income areas of Asia Pacific. According to the U.K. National Health Service (NHS), acne is very common in teenagers and young adults. Around 95% of people aged 11 to 30 across the country are affected by acne to some extent.

Figure 1. Global Acne Therapeutics Market Share (%), by Region, 2023

To learn more about this report, request sample copy

Global Acne Therapeutics Market Drivers:

Growing burden of acne to augment market growth

One of the key factors expected to augment the growth of the global acne therapeutics market over the forecast period is the growing prevalence of acne across the world. For instance, acne is a skin condition that occurs when hair follicles become plugged with oil and dead skin cells. It is most common among teenagers, though it affects people of all ages. According to the National Institutes of Health (NIH), acne affect more than 9.4% of the global population, making it one of the most prevalent disease worldwide. This in turn increase the demand for safe/effective acne therapeutics, driving the growth of the global acne therapeutics market.

High demand for acne therapeutics to drive market growth

Another factor which is driving the growth of the global acne therapeutics market is the increasing demand for safe and effective acne therapeutics worldwide. For instance, with the growing burden of acne across the globe, the demand for acne therapeutics is also increasing rapidly. In July 2022, Glenmark Pharmaceuticals launched India's first topical Minocycline 4% Gel for the treatment of moderate to severe acne, under the brand name MINYM. Minocycline is a potent antibacterial gel which exerts a strong anti-inflammatory action. MINYM Gel has been developed for the treatment of acne and is safe to use in patients above 9 years of age.

Global Acne Therapeutics Market Opportunities:

Increasing research and development (R&D) is expected to offer significant growth opportunities for players in the acne therapeutics market. For instance, in April 2021, in Canada, Bausch Health’s subsidiary Ortho Dermatologics announced positive topline data from its second Phase III trial for IDP-126, a three-compound combination gel tested in 193 patients with acne vulgaris. This clinical trial showed reductions in inflammatory & non-inflammatory lesions in 12 week in both problems. Such research around the products and combination of retinoids are expected to increase both the manufacturing and sales of the same.

Growing awareness among people about acne products and available treatment options is expected to offer significant growth opportunities for players in the acne therapeutics market. For instance, acne is one of the most common skin condition, and despite its prevalence, few people around the world know that June is acne awareness month. Acne Awareness Month is celebrated every June to discuss treatments and reduce stigma associated with the condition. Therefore, it is important to ensure that individuals suffering from acne are aware of its impact or effects and seek appropriate medical intervention. This in turn is expected to drive market growth.

Global Acne Therapeutics Market Trends:

High demand for creams and gels is a recent trend

Retinoid creams and gels are very effective at stopping or reducing mild to moderate acne, which led to an increasing demand for retinoids. For instance, in February 2022, Stryke Club announced the launch of retinoid acne treatment with its Knockout Adapalene Gel that helps prevent pimples, blackheads, whiteheads, and clogged pores. The rising product launches of retinoid treatment will lead to increasing adoption of the same owing to its benefits, and this trend is expected to continue over the forecast period, driving the market growth.

Introduction of novel drugs is another trend

With the growing burden of acne, the demand for acne therapeutics is also increasing. As a result, players in the market are focusing on developing and launching novel therapeutics in the market. In November 2021, Sun Pharmaceuticals announced the launch of Winlevi (Clascoterone cream 1%), the first-in-class topical therapy for acne vulgaris, in the United States. WINLEVI is approved by FDA for the topical treatment of acne vulgaris in patients 12 years of age and older. This trend is also expected to continue over the forecast period.

Global Acne Therapeutics Market Restraints:

Increasing demand for generics to hinder market growth

One of the key factors expected to hamper the growth of the global acne therapeutics market is the increasing demand for generic drugs or increasing adoption of generic drugs. In a few cases, though branded versions are not available their generic versions are available in the market. For instance, Isotretinoin is no longer available under a brand Accutane, but is still available as a generic version. Generics offer a low-cost alternative to a branded counterparts, and thus, customer prefer generic drugs over branded drugs, restraining the growth of the market.

Issues regarding acne products to hamper market growth

Another factor which is hampering the growth of the global acne therapeutics market is the safety issues regarding acne products. Acne products are generally considered safe. However, according to the Food and Drug Administration (FDA), the use of certain acne products containing the active ingredients benzoyl peroxide or salicylic acid, can cause rare but serious as well as potentially life-threatening allergic reactions or severe irritation. Due to the high incidence of these side-effects, FDA has warned consumers about these safety issues.

Figure 2. Global Acne Therapeutics Market Share (%), by Treatment, 2023

To learn more about this report, request sample copy

Global Acne Therapeutics Market Segmentation:

The global acne therapeutics market report is segmented into Treatment, Route of Administration, and Geography.

Based on Treatment, the acne therapeutics market is segmented into Therapeutics, Retinoid, Antibiotics, Hormonal Agents, Combination Medications, Anti-inflammatory, and Other Agents. Out of which, Therapeutics Segment is expected to dominate the acne therapeutics market over the forecast period and this is attributed to the increasing demand for acne therapeutics.

Retinoid Segment is also expected to witness robust growth in the near future and this is owing to the increasing demand for retinoid creams and gels.

Based on Route of Administration, the market is segmented into Oral, Topical, and Others. Out of which, Oral Segment is expected to dominate the market over the forecast period and this is attributed to the increasing demand for oral therapeutics.

Topical Segment is also expected to witness significant growth in the near future and this is owing to increasing demand for topical therapeutics.

Global Acne Therapeutics Market: Key Developments

In May 2023, Crown Therapeutics, a division of Crown Laboratories, announced that PanOxyl is expanding its award-winning portfolio with PM Balancing Repair Moisturizer and reformulating the existing AM Oil Control Moisturizer.

In July 2022, Sun Pharmaceutical Industries expanded the scope of its partnership with Cassiopea regarding a medication to treat acne. It has inked addendums to the licence and supply agreements for WINLEVI (clascoterone) cream 1 per cent, expanding the territory to include Japan, Australia, New Zealand, Brazil, Mexico and Russia.

In July 2022, STRATA Skin Sciences, Inc. announced the commercial launch of TheraClearX, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular and inflammatory acne vulgaris.

Global Acne Therapeutics Market: Key Companies Insights

The global acne therapeutics market is highly competitive. This is attributed to the growing burden of acne and increasing demand for acne therapeutics, as a result, players in the market are focusing on developing and launching novel drugs in the market.

Some of the key players in the global acne therapeutics market are Allergan, Ranbaxy, Bayer Ag, Johnson & Johnson, Nestlé SA (Galderma), Glaxosmithkline Plc, Teva Pharmaceuticals, Cipher Pharmaceuticals, F. Hoffmann-la Roche Ltd., and Valeant Pharmaceuticals International Inc.

*Definition: Acne is a common skin condition where the pores of the skin clog, and pore blockages produce blackheads, whiteheads, and other types of pimples. Treatments include over-the-counter creams and cleanser, as well as prescription antibiotics.